Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (421)	2/9/1999 11:47:00 AM
From: John Dwyer	Read Replies (1) \| Respond to of 4974

I didn't see this get posted here... (NewsTraders.com)-- Biotechnology Value Fund L.P. increased its stake in Progenics Pharmaceuticals Inc. (PGNX) to 6.2% from 5.2%, and now has ownership of 573,000 common shares, according to an amended Schedule 13D filed yesterday after market close. Recent transactions include the purchase of 91,200 shares between Dec. 16, 1998, and Jan. 25 at prices ranging from $11.50 to $13.50. Copyright 1999 NewsTraders Inc. All Rights Reserved 08:44 Thursday, February 04, 1999